- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/10 - Peptides having 12 to 20 amino acids
Patent holdings for IPC class A61K 38/10
Total number of patents in this class: 4326
10-year publication summary
|
286
|
340
|
325
|
396
|
290
|
291
|
232
|
254
|
185
|
152
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20802 |
79 |
| GemVax & Kael Co., Ltd. | 96 |
46 |
| Biolinerx Ltd. | 75 |
35 |
| Ironwood Pharmaceuticals, Inc. | 154 |
35 |
| Biokine Therapeutics Ltd. | 59 |
34 |
| The Trustees of the University of Pennsylvania | 4426 |
32 |
| Bausch Health Ireland Limited | 802 |
32 |
| Nymox Corporation | 37 |
30 |
| The Johns Hopkins University | 5907 |
29 |
| Peptidream Inc. | 107 |
28 |
| Apellis Pharmaceuticals, Inc. | 134 |
25 |
| Protagonist Therapeutics, Inc. | 154 |
25 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3322 |
24 |
| Caregen Co., Ltd. | 338 |
23 |
| Mondobiotech Laboratories AG | 311 |
23 |
| NoNO Inc. | 68 |
23 |
| Agency for Science, Technology and Research | 3744 |
21 |
| Bicyclerd Limited | 151 |
21 |
| Centre National de La Recherche Scientifique | 11055 |
20 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
20 |
| Other owners | 3721 |